## NKE: NIKE, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -1.0% below STRENGTH zone (3.0-6.0%); PEG 2.52 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($57.43)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Tim Cook's Nike Buy, AI Smart Glasses, Court Victory And More: This Week In Appleverse**
- Source: Benzinga | 20251228T120751 | Somewhat-Bullish | Relevance: 94%
- This article summarizes key Apple-related news, including CEO Tim Cook's recent significant investment in Nike. It also highlights Apple's plans for AI-powered smart glasses and AirPods by 2026, a court victory against a Texas child safety law, and the introduction of a new "iPhone Sock" accessory.

**2. The Biggest IPO of the Year Prompts Huge Insider Buy**
- Source: 24/7 Wall St. | 20251230T134756 | Neutral | Relevance: 65%
- This article details significant insider purchases in several companies, highlighted by beneficiaries buying into Medline Inc. following the year's largest IPO. Other notable insider buys include Kodiak Sciences and W.R. Berkley, with the article emphasizing that insider buying is often an encouraging signal for potential investors. It examines the specifics of these transactions, including the companies involved, the buyers, and the financial details of their investments.

**3. Apple Inc. $AAPL Stock Position Trimmed by WestHill Financial Advisors Inc.**
- Source: MarketBeat | 20251229T130246 | Neutral | Relevance: 64%
- WestHill Financial Advisors Inc. reduced its stake in Apple Inc. ($AAPL) by 4.9%, selling 2,156 shares to hold 41,971 shares valued at $10.687 million, making Apple its 10th largest holding. Concurrently, Apple CEO Tim Cook and SVP Deirdre O'Brien also sold significant amounts of company stock. Despite insider selling, large institutions like Vanguard and State Street increased their positions, and Apple reported strong quarterly EPS, while analysts maintain a "Moderate Buy" rating with an average target price of $283.92.

**4. Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up**
- Source: ts2.tech | 20251230T200852 | Neutral | Relevance: 63%
- Lululemon's stock slipped after founder Chip Wilson initiated a proxy fight to reshape the board amidst a CEO transition and declining share value. Wilson nominated three new board members and proposes declassifying the board, while the company plans to review the nominations ahead of its 2026 annual meeting. This challenge follows a significant drop in Lululemon's stock value in 2025 and increased activist pressure.

**5. UBS reiterates Buy rating on Deckers stock, citing Hokaâ€™s growth potential**
- Source: Investing.com India | 20251230T070827 | Neutral | Relevance: 61%
- UBS has reiterated its Buy rating and $157.00 price target for Deckers Outdoor, primarily driven by the significant growth potential of its Hoka footwear brand. Despite a challenging year for the stock, Hoka is projected to achieve a 13% four-year sales compound annual growth rate, and its brand awareness, currently at 20%, suggests considerable room for expansion compared to competitors. The firm anticipates Hoka's strong momentum will lead to calendar year 2026 sales growth and earnings surpassing market expectations.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 13)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | UBS | $62 | $71 | -13% |
| 2025-12-19 | Citigroup | $65 | $70 | -7% |
| 2025-12-19 | Barclays | $64 | $70 | -9% |
| 2025-12-19 | Truist Securiti | $70 | $85 | -18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | UBS | main | Neutral |
| 2025-12-19 | Citigroup | main | Neutral |
| 2025-12-19 | Barclays | main | Equal-Weight |
| 2025-12-19 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 10 ($4.45M) |
| Sells | 4 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (+1.3%)
- Blackrock Inc.: 7.7% (-0.1%)
- State Street Corpora: 4.9% (-1.9%)
- Capital World Invest: 3.5% (+0.7%)
- JPMORGAN CHASE & CO: 2.7% (+72.1%)

### Key Risks

1. Long-term trend broken: trading 8.3% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.52 signals overvaluation risk, limited margin of safety. Forward P/E 25.4x attractive for 51% earnings growth. Balance sheet: strong liquidity (2.1x). Analyst sentiment negative (13 target cuts vs 0 raises). Insider buying signal ($4.5M), management confidence. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $90.5B |
| Beta | 1.29 |
| 52W Range | $52.28 - $82.44 |
| Short Interest | 3.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.52 |
| Forward P/E | 25.4 |
| Current P/E | 38.2 |
| YoY Growth | 50.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -11.7% to -1.0% (+10.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.0pp (needs >3.0% for momentum thesis). MRS_5 turning positive (2.2%) - potential reversal signal. Below SMA200 (0.92x), long-term trend not supportive. RSI neutral at 44. OFD pattern: -DLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.99% (CS: 31) | Neutral |
| RSI_14 | 43.6 | Neutral |
| MACD Histogram | -0.39 | Bearish |
| vs SMA20 | 0.961x | Below |
| vs SMA50 | 0.954x | Below |
| vs SMA200 | 0.917x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $61.19
- **Stop Loss:** $57.43 (6.1% risk)
- **Target:** $64.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 292
- **Position Value:** $17,867.48
- **Portfolio %:** 17.87%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.37 | $0.53 | +41.9% |
| 2025Q3 | $0.27 | $0.49 | +84.5% |
| 2025Q2 | $0.12 | $0.14 | +13.5% |
| 2025Q1 | $0.28 | $0.54 | +94.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*